SQUADRITO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 8.330
EU - Europa 5.356
AS - Asia 4.324
SA - Sud America 1.820
AF - Africa 141
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.980
Nazione #
US - Stati Uniti d'America 8.153
SG - Singapore 1.757
BR - Brasile 1.615
IE - Irlanda 1.364
CN - Cina 1.310
SE - Svezia 1.210
IT - Italia 639
HK - Hong Kong 585
DE - Germania 555
UA - Ucraina 399
FI - Finlandia 290
VN - Vietnam 224
RU - Federazione Russa 190
GB - Regno Unito 189
PL - Polonia 138
IN - India 133
FR - Francia 118
CA - Canada 92
AR - Argentina 73
BE - Belgio 55
ZA - Sudafrica 45
MX - Messico 42
AT - Austria 41
TR - Turchia 39
BD - Bangladesh 37
EC - Ecuador 36
ID - Indonesia 35
ES - Italia 34
NL - Olanda 31
EE - Estonia 29
IQ - Iraq 29
MA - Marocco 26
JP - Giappone 24
CO - Colombia 22
UZ - Uzbekistan 22
LT - Lituania 18
CI - Costa d'Avorio 17
PY - Paraguay 17
CZ - Repubblica Ceca 16
CL - Cile 15
VE - Venezuela 15
AE - Emirati Arabi Uniti 14
IL - Israele 13
PK - Pakistan 13
KE - Kenya 12
IR - Iran 11
PE - Perù 11
AZ - Azerbaigian 10
EG - Egitto 9
JM - Giamaica 9
JO - Giordania 9
UY - Uruguay 9
NP - Nepal 8
TN - Tunisia 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
HN - Honduras 7
KZ - Kazakistan 7
LB - Libano 7
AL - Albania 6
CR - Costa Rica 6
PA - Panama 6
DZ - Algeria 5
KG - Kirghizistan 5
LV - Lettonia 5
OM - Oman 5
PT - Portogallo 5
CH - Svizzera 4
SA - Arabia Saudita 4
AO - Angola 3
BG - Bulgaria 3
BH - Bahrain 3
BW - Botswana 3
GR - Grecia 3
KH - Cambogia 3
KW - Kuwait 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
RO - Romania 3
SN - Senegal 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
EU - Europa 2
GT - Guatemala 2
KR - Corea 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
SV - El Salvador 2
TG - Togo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
Totale 19.966
Città #
Dublin 1.364
Dallas 1.288
Ashburn 1.236
Chandler 958
Singapore 900
Jacksonville 803
Nyköping 654
Hong Kong 585
Beijing 539
Messina 237
Los Angeles 203
Princeton 201
Medford 189
The Dalles 176
Ann Arbor 163
Munich 163
Cambridge 150
Des Moines 150
São Paulo 137
New York 132
Warsaw 128
Boardman 123
Dearborn 96
Ho Chi Minh City 90
Buffalo 87
Turku 71
Woodbridge 66
Redondo Beach 64
Nuremberg 62
Wilmington 62
Jinan 58
Moscow 57
Helsinki 56
Brussels 55
Tianjin 51
Rio de Janeiro 49
Rome 48
Hanoi 46
Belo Horizonte 45
Shenyang 44
Houston 42
Nanjing 42
Hebei 40
Hyderabad 40
Brooklyn 37
Ottawa 37
Pune 37
San Mateo 37
Frankfurt am Main 36
Bremen 34
Seattle 34
Brasília 32
Haikou 32
Lancaster 29
Chicago 28
Phoenix 28
Porto Alegre 28
Stockholm 28
Guangzhou 27
Ningbo 26
Vienna 26
Catania 25
Montreal 25
Zhengzhou 25
Jakarta 24
Tokyo 24
Hangzhou 22
Nanchang 22
San Francisco 22
Santa Clara 22
Boston 21
Chennai 21
Rosolini 21
Johannesburg 20
London 20
Orem 19
Curitiba 18
Düsseldorf 18
Taizhou 18
Tashkent 18
Abidjan 17
Campinas 17
Denver 17
Guarulhos 17
Poplar 17
Lappeenranta 16
Baghdad 15
Changsha 15
Amsterdam 14
Auburn Hills 14
Goiânia 14
Mumbai 14
Sorocaba 14
Atlanta 13
Augusta 13
Mexico City 13
Columbus 12
Council Bluffs 12
Fuzhou 12
Osasco 12
Totale 12.979
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 322
Adenosine Receptor Stimulation by Polydeoxyribonucleotide Improves Tissue Repair and Symptomology in Experimental Colitis. 278
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 205
17 beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat 204
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 191
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 188
Activation of the cholinergic anti-inflammatory pathway reduces NF-kappa B activation, blunts TNF-alpha production, and protects against splanchnic artery occlusion shock 175
Atrial fibrillation in patients with cirrhosis 174
Abnormal left ventricular global strain during exercise-test in young healthy smokers 174
Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy 167
Dual-source dual-energy CT in the evaluation of hepatic fractional extracellular space in cirrhosis 162
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 153
Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis. 152
Effects of adrenergic stimulation on transmembrane transport of Na+ in patients with essential hypertension 147
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 144
CORRELATION BETWEEN URINARY ACTIVITY OF N-ACETYL-B-D-GLUCOSAMINIDASE (NAG) AND ALBUMIN EXCRETION RATE IN TYPE II (NON INSULIN-DEPENDENT) DIABETICS SUBJECTS. 141
A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation 139
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 136
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 133
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 131
ALENDRONATE TAIL EFFECT ON BONE IS MODULATED BY VITAMIN D: A RETROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 131
An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers 130
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 128
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 127
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 127
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two–Lipid Center Real-World Experience 126
The reduction of myocardial damage and leukocyte polymorphonuclear accumulation following coronary artery occlusion by the tyrosine kinase inhibitor tyrphostin AG 556 124
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 123
Clinical virology of hepatitis B virus infection 122
Antioxidant activity of U-83836E, a second generation lazaroid, during myocardial ischemia/reperfusion injury 122
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 121
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 119
Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care 118
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 118
Inhibition of nuclear factor-kappa B activation by IRFI 042, protects against endotoxin-induced shock 117
Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock 117
Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury 117
Valutazione elastografica (fibroscan) del fegato nelle pazienti con sindrome di Turner 117
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 116
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 116
Anxiety levels predict bone mineral density in postmenopausal women undergoing oral bisphosphonates: A two-year follow-up 115
Erectile dysfunction in compensated liver cirrhosis 115
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 114
Expression and change of mirs 145, 221 and 222 in hypertensive subjects treated with enalapril, losartan or olmesartan 112
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 111
ARA-C a basse dosi nelle sindrome mielodisplastiche in differenti stati evolutivi 111
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection 111
Circulating levels of intercellular adhesion Molecule-1 (ICAM-1) and soluble Interleukin 2 receptors(IL-2R) in patients with B cell Chronic Lynphocityc Leukemia 110
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 110
Effect of beta blockade on the erythrocyte transport of Na+: evaluation during stimulation by cold pressure test in patients with essential hypertension] 109
Cardiovascular effects of raloxifene hydrochloride 109
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 109
ANTIBODIES AGAINST INTERCELLULAR-ADHESION MOLECULE-1 PROTECT AGAINST MYOCARDIAL ISCHEMIA-REPERFUSION INJURY IN RAT 107
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 107
Alexithymia and asthma: a systematic review 107
Update of the statements on biology and clinical impact of occult hepatitis B virus infection 106
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 106
Evidence for a role of nuclear factor-kappa B in acute hypovolemic hemorrhagic shock 105
G-619, A DUAL THROMBOXANE SYNTHASE INHIBITOR AND THROMBOXANE A(2) RECEPTOR ANTAGONIST, INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA BIOSYNTHESIS 105
Inhibition of tumour necrosis factor and reversal of endotoxin- induced shock by U-83836E, a 'second generation' lazaroid in rats 105
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 105
Fibroscan: a new non invasive method for cross-sectional and longitudinal evaluation of liver dysfunction in Turner syndrome 105
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 104
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 104
Arterial Stiffness and Adult Onset Vasculitis: A Systematic Review 104
Reduction of carbon tetrachloride-induced rat liver injury by IRFI 042, a novel dual vitamin E-like antioxidant. 102
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta superinfection. 102
The reduction of myocardial damage and leukocyte polymorphonuclear accumulation following coronary artery occlusion by the tyrosine kinase inhibitor tyrphostin AG 556 102
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 102
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 102
Effects of cloricromene on the levels of endothelin and on the microcirculatory function in peripheral atherosclerotic arteriopathies 101
Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury 101
Use of a balanced dual cyclooxygenase-1/2 and 5-lypoxygenase inhibitor in experimental colitis 101
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 101
Effectiveness of add-on Pegylated interferon alfa-2a therapy in a Lamivudine-treated patient with chronic hepatitis B 100
Polydeoxyribonucleotide: A Promising Biological Platform to Accelerate Impaired Skin Wound Healing 100
The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shock 99
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 99
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 98
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 98
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 97
Endotoxin tolerance impairs a pertussis-toxin-sensitive G- protein regulating tumour necrosis factor release by macrophages from tumour-bearing rats 97
Gender differences in diabetic kidney disease: Focus on hormonal, genetic and clinical factors 97
Nutraceuticals: A New Challenge against Cadmium‐Induced Testicular Injury 97
HCV NS5A mutations and response of chronic hepatitis to alpha interferon. 96
Gene transfer of I kappa B alpha limits infarct size in a mouse model of myocardial ischemia-reperfusion injury 96
Evaluation of liver stiffness using transient elastography (fibroscan) in young adults with Turner syndrome. 96
Pharmacogenetics of biological agents used in inflammatory bowel disease: A systematic review 96
High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. 95
Impact of Occult Hepatitis B Virus Infection on the Outcome of Chronic Hepatitis C. 95
Dual-energy CT quantification of fractional extracellular space in cirrhotic patients: comparison between early and delayed equilibrium phases and correlation with oesophageal varices 95
Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice 95
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 94
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 94
Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients 94
Effect of sulfatide on acute lung injury during endotoxemia in rats 93
Efferent vagal fibre stimulation blunts nuclear factor-kappa B activation and protects against hypovolemic hemorrhagic shock 93
The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats 93
Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study 91
Prevalence of pulmonary hypertension in an unselected community-based population: A retrospective echocardiographic study-res-ph study 91
Totale 12.061
Categoria #
all - tutte 79.525
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.525


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021663 0 0 0 0 0 130 31 144 93 124 94 47
2021/20221.482 25 168 36 42 97 7 99 59 29 297 171 452
2022/20233.905 286 386 164 281 286 403 62 230 1.605 26 132 44
2023/20241.271 76 138 62 121 82 221 14 272 4 86 76 119
2024/20254.793 107 60 80 278 210 180 220 983 1.123 323 428 801
2025/20265.320 764 1.120 1.150 972 1.172 142 0 0 0 0 0 0
Totale 20.406